Unfortunately, investing is risky - companies can and do go bankrupt. But if you pick the right stock, you can make a lot more than 100%. For example, the Lifecome Biochemistry Co.,Ltd. (SZSE:002868) share price has soared 151% return in just a single year. It's also good to see the share price up 98% over the last quarter. This could be related to the recent financial results, released recently - you can catch up on the most recent data by reading our company report. And shareholders have also done well over the long term, with an increase of 84% in the last three years.
In light of the stock dropping 9.2% in the past week, we want to investigate the longer term story, and see if fundamentals have been the driver of the company's positive one-year return.
Check out our latest analysis for Lifecome BiochemistryLtd
While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.
During the last year Lifecome BiochemistryLtd saw its earnings per share (EPS) drop below zero. While this may prove temporary, we'd consider it a negative, so we would not have expected to see the share price up. It may be that the company has done well on other metrics.
However the year on year revenue growth of 9.8% would help. Many businesses do go through a phase where they have to forgo some profits to drive business development, and sometimes its for the best.
The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).
![earnings-and-revenue-growth](https://usnewsfile.futunn.com/pic/0-14930350-0-689d41b1d17a9f147d58cf24b10cd0dc.png/big)
SZSE:002868 Earnings and Revenue Growth September 22nd 2022
Take a more thorough look at Lifecome BiochemistryLtd's financial health with this free report on its balance sheet.
A Different Perspective
It's nice to see that Lifecome BiochemistryLtd shareholders have received a total shareholder return of 151% over the last year. Since the one-year TSR is better than the five-year TSR (the latter coming in at 6% per year), it would seem that the stock's performance has improved in recent times. Given the share price momentum remains strong, it might be worth taking a closer look at the stock, lest you miss an opportunity. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Case in point: We've spotted 3 warning signs for Lifecome BiochemistryLtd you should be aware of.
If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on CN exchanges.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
不幸的是,投资是有风险的--公司可能而且确实会破产。但如果你选对了股票,你可以赚很多钱更多而不是100%。例如,生命美生物化学有限公司。[SZSE:002868]股价在短短一年内飙升了151%的回报率。上个季度股价上涨了98%,这也是件好事。这可能与最近发布的财务业绩有关-您可以通过阅读我们的公司报告来了解最新的数据。从长期来看,股东的表现也很好,过去三年的涨幅为84%。
鉴于该公司股价在过去一周下跌了9.2%,我们希望调查更长期的情况,看看基本面因素是否是该公司一年来正回报的驱动因素。
查看我们对Lifecome BioChemical Ltd.的最新分析
虽然有效市场假说继续被一些人传授,但事实证明,市场是过度反应的动态系统,投资者并不总是理性的。通过比较每股收益(EPS)和股价随时间的变化,我们可以感受到投资者对一家公司的态度随着时间的推移发生了怎样的变化。
在过去的一年里,生命生命生物化学有限公司的每股收益(EPS)跌至零以下。虽然这可能被证明是暂时的,但我们会认为这是负面的,所以我们不会指望看到股价上涨。这可能是因为该公司在其他指标上表现良好。
然而,9.8%的同比收入增长将有所帮助。许多企业确实经历了一个阶段,他们不得不放弃一些利润来推动业务发展,有时这是最好的。
下图描述了收益和收入随时间的变化(通过单击图像来揭示确切的价值)。
![earnings-and-revenue-growth](https://usnewsfile.futunn.com/pic/0-14930350-0-689d41b1d17a9f147d58cf24b10cd0dc.png/big)
深交所:2022年9月22日收益和收入增长002868
更全面地了解Lifecome BioChemical Ltd.的财务状况免费报告其资产负债表。
不同的视角
很高兴看到生命生物化学有限公司的股东在过去一年中获得了151%的总股东回报。由于一年期的TSR好于五年期的TSR(后者的年收益率为6%),看起来该股的表现最近有所改善。鉴于股价势头依然强劲,仔细观察这只股票可能是值得的,以免错过预期和机会。我发现,把股价作为衡量企业业绩的长期指标是非常有趣的。但为了真正获得洞察力,我们还需要考虑其他信息。一个恰当的例子:我们发现了Lifecome生化有限公司的3个警告标志你应该意识到。
如果你像我一样,你会的不想怀念这一切吗?免费内部人士正在收购的成长型公司名单。
请注意,本文引用的市场回报反映了目前在CN交易所交易的股票的市场加权平均回报。
对这篇文章有什么反馈吗?担心内容吗? 保持联系直接与我们联系。或者,也可以给编辑组发电子邮件,地址是implywallst.com。
本文由Simply Wall St.撰写,具有概括性。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。Simply Wall St.对上述任何一只股票都没有持仓。